Tysabri every eight weeks may cut PML risk
Tysabri every eight weeks may cut PML risk
Preliminary findings from an ongoing study of multiple sclerosis patients suggest the dosing interval for Tysabri can be as much as doubled from the label-recommended standard without sacrificing efficacy, and with potentially less risk of progressive multifocal leukoencephalopathy (PML) -- even among patients with more than average PML risk, researchers claim... Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2582 Views
-
Last post by NHE
-
- 0 Replies
- 555 Views
-
Last post by NHE
-
- 6 Replies
- 7845 Views
-
Last post by ElliotB
-
- 0 Replies
- 3814 Views
-
Last post by NHE
-
- 0 Replies
- 1425 Views
-
Last post by NHE
-
- 0 Replies
- 655 Views
-
Last post by NHE
-
- 0 Replies
- 3506 Views
-
Last post by NHE
-
- 11 Replies
- 3535 Views
-
Last post by NHE
-
- 1 Replies
- 1162 Views
-
Last post by NHE